Your browser doesn't support javascript.
loading
21-Gene Recurrence Score Assay Could Not Predict Benefit of Post-mastectomy Radiotherapy in T1-2 N1mic ER-Positive HER2-Negative Breast Cancer.
Zhang, Wen-Wen; Tong, Qin; Sun, Jia-Yuan; Hua, Xin; Long, Zhi-Qing; Deng, Jia-Peng; Dong, Yong; Li, Feng-Yan; He, Zhen-Yu; Wu, San-Gang; Lin, Huan-Xin.
Affiliation
  • Zhang WW; State Key Laboratory of Oncology in Southern China, Department of Radiation Oncology, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Tong Q; Department of Radiation Oncology, The First Affiliated Hospital of University of South China, Hengyang, China.
  • Sun JY; State Key Laboratory of Oncology in Southern China, Department of Radiation Oncology, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Hua X; State Key Laboratory of Oncology in Southern China, Department of Radiation Oncology, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Long ZQ; State Key Laboratory of Oncology in Southern China, Department of Radiation Oncology, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Deng JP; State Key Laboratory of Oncology in Southern China, Department of Radiation Oncology, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Dong Y; Department of Oncology, Dongguan Third People's Hospital, Affiliated Dongguan Shilong People's Hospital of Southern Medical University, Guangdong, China.
  • Li FY; State Key Laboratory of Oncology in Southern China, Department of Radiation Oncology, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • He ZY; State Key Laboratory of Oncology in Southern China, Department of Radiation Oncology, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Wu SG; Department of Radiation Oncology, Xiamen Cancer Hospital, The First Affiliated Hospital of Xiamen University, Xiamen, China.
  • Lin HX; State Key Laboratory of Oncology in Southern China, Department of Radiation Oncology, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
Front Oncol ; 9: 270, 2019.
Article de En | MEDLINE | ID: mdl-31041190
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Langue: En Journal: Front Oncol Année: 2019 Type de document: Article Pays d'affiliation: Chine
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Langue: En Journal: Front Oncol Année: 2019 Type de document: Article Pays d'affiliation: Chine